Researchers have uncovered a surprising immune-system switch in the brain that could open a new avenue in the fight the ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Tracking body fat over a 35-year period reveals that excess belly fat in midlife is linked to a higher risk of Alzheimer’s ...

The study found that blood biomarkers associated with self-reported memory concerns may offer early clues for how the disease may later develop. This association suggests that “AD [Alzheimer’s disease ...

Scientists have identified a previously unrecognized feature of Alzheimer’s disease in the form of clustered, damaged cellular power plants within nerve fibers. These structures, dubbed “mitochondrial ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.

Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...

Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical ...

Social media posts about blood tests meant to aid in the diagnosis of Alzheimer’s disease often leave out critical ...

The Alzheimer’s disease biomarker market is experiencing steady growth, driven by the rising prevalence of Alzheimer’s disease and dementia, increasing emphasis on early and accurate diagnosis, and ...

The Alzheimer’s Association invites Santa Barbara residents to join the fight to end Alzheimer’s by participating in the Alzheimer’s Association Walk to ...